1
|
Wisse JJ, Somhorst P, Behr J, van Nieuw Amerongen AR, Gommers D, Jonkman AH. Improved filtering methods to suppress cardiovascular contamination in electrical impedance tomography recordings. Physiol Meas 2024. [PMID: 38697210 DOI: 10.1088/1361-6579/ad46e3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/04/2024]
Abstract
OBJECTIVE Electrical Impedance Tomography (EIT) produces clinical useful visualization of the distribution of ventilation inside the lungs. The accuracy of EIT-derived parameters can be compromised by the cardiovascular signal. Removal of these artefacts is challenging due to spectral overlapping of the ventilatory and cardiovascular signal components and their time-varying frequencies. We designed and evaluated advanced filtering techniques and hypothesized that these would outperform traditional low-pass filters.
Approach: Three filter techniques were developed and compared against traditional low-pass filtering: multiple digital notch filtering (MDN), empirical mode decomposition (EMD) and the maximal overlap discrete wavelet transform (MODWT). The performance of the filtering techniques was evaluated 1) in the time domain 2) in the frequency domain 3) by visual inspection. We evaluated the performance using simulated contaminated EIT data and data from fifteen adult and neonatal ICU patients.
Main result: Each filter technique exhibited varying degrees of effectiveness and limitations. Quality measures in the time domain showed the best performance for MDN filtering. The signal to noise ratio was best for DLP, but at the cost of a high relative and removal error. MDN outbalanced the performance resulting in a good SNR with a low relative and removal error. MDN, EMD and MODWT performed similar in the frequency domain and were successful in removing the high frequency components of the data.
Significance: Advanced filtering techniques have benefits compared to traditional filters but are not always better. MDN filtering outperformed EMD and MODWT regarding quality measures in the time domain. This study emphasizes the need for careful consideration when choosing a filtering approach, depending on the dataset and the clinical/research question.
.
Collapse
Affiliation(s)
- Jantine J Wisse
- Department of Adult Intensive Care, Erasmus Medical Center, Dr. Molewaterplein 40, Rotterdam, Zuid-Holland, 3015 GD, NETHERLANDS
| | - P Somhorst
- Department of Adult Intensive Care, Erasmus Medical Center, Dr. Molewaterplein 40, Rotterdam, Zuid-Holland, 3015 GD, NETHERLANDS
| | - J Behr
- Department of Adult Intensive Care, Erasmus Medical Center, Dr. Molewaterplein 40, Rotterdam, Zuid-Holland, 3015 GD, NETHERLANDS
| | - A R van Nieuw Amerongen
- Department of Adult Intensive Care, Erasmus Medical Center, Dr. Molewaterplein 40, Rotterdam, Zuid-Holland, 3015 GD, NETHERLANDS
| | - D Gommers
- Department of Adult Intensive Care, Erasmus Medical Center, Dr. Molewaterplein 40, Rotterdam, Zuid-Holland, 3015 GD, NETHERLANDS
| | | |
Collapse
|
2
|
Amstutz C, Behr J, Krebs S, Haeberlin A, Vogel R, Zurbuchen A, Burger J. Design of percutaneous transluminal coronary angioplasty balloon catheters. Biomed Eng Online 2023; 22:94. [PMID: 37742021 PMCID: PMC10517552 DOI: 10.1186/s12938-023-01155-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Accepted: 09/15/2023] [Indexed: 09/25/2023] Open
Abstract
BACKGROUND Eight commercially available percutaneous transluminal coronary angioplasty (PTCA), including semi-compliant and non-compliant balloons, have been assessed in detail on their tip, balloon, shaft, RX-Port, and hypotube design. Important performance characteristics such as tip deformation, balloon elongation, and deflation rate have been quantified. METHODS Five catheters of each model were evaluated during various tests. The robustness of the tips was evaluated through compression, measuring any occurrence of damage. The longitudinal growth of the balloons was recorded during inflation up to Rated Burst Pressure (RBP). The forces required to move the catheter forward and retract it into the guide catheter were measured in a simulated use test setup. The deflation behavior was studied by measuring extracted contrast media over time. Furthermore, balloon compliance and catheter dimensions were investigated. RESULTS The outer dimensions of the catheter were found to be smallest at the hypotube (0.59-0.69 mm) and highest at the balloon, respectively, the crossing profile (0.9-1.2 mm). The tip diameter increased after compression by 1.7-22%. Cross-sections of the folded balloons revealed a tri- and two-fold, respectively. The measured balloon elongation ranged from 0.6 to 2.0 mm. After the inflation of the balloon, an increase in friction between the guide wire and the catheter was observed on four catheters. A maximum increase of 0.12 N to 1.07 N was found. Cross-sections of the RX-Port revealed a semicircular-shaped inflation lumen and a circular guide wire lumen. The measured deflation rate ranged from 0.004 to 0.013 µL/s, resulting in an estimated balloon deflation time of 10.2-28.1 s. CONCLUSION This study provides valuable insights into the design characteristics of RX PTCA balloon catheters, which can contribute to facilitating the development of improved catheter designs and enhancing clinical outcomes. Distinctions between SC and NC catheters, such as balloon performance and dimensions, are evident. It is important to note that no single catheter excels in all aspects, as each possesses unique strengths. Therefore, it is essential to consider individual intervention requirements when selecting a catheter. The research also identifies specific catheter weaknesses, such as reduced wall thickness, fringes at the tip, and reduced performance characteristics.
Collapse
Affiliation(s)
- C. Amstutz
- School of Biomedical and Precision Engineering, University of Bern, Güterstrasse 24/26, CH-3008 Bern, Switzerland
| | - J. Behr
- SMD Swiss Medical Devices, Beringen, Switzerland
| | - S. Krebs
- School of Biomedical and Precision Engineering, University of Bern, Güterstrasse 24/26, CH-3008 Bern, Switzerland
| | - A. Haeberlin
- Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - R. Vogel
- Department of Cardiology, Buergerspital Solothurn, Solothurn, Switzerland
| | - A. Zurbuchen
- School of Biomedical and Precision Engineering, University of Bern, Güterstrasse 24/26, CH-3008 Bern, Switzerland
- Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
| | - J. Burger
- School of Biomedical and Precision Engineering, University of Bern, Güterstrasse 24/26, CH-3008 Bern, Switzerland
| |
Collapse
|
3
|
Naehrig S, Breuling M, Mertsch P, Behr J. 53 Pregnancies in women with cystic fibrosis with or without intake of elexacaftor/tezacaftor/ivacaftor. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)00744-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
4
|
Reitmeier R, Walter J, Behr J, Mertsch P. 179 Inflammation-based scoring systems and ratios to identify people with cystic fibrosis at risk for intravenous antibiotic therapy. J Cyst Fibros 2022. [DOI: 10.1016/s1569-1993(22)00869-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
5
|
Walter J, Kovàcs J, Munker D, Sellmer L, Kauke T, Behr J, Barton J, Kneidinger N, Schneider C, Tufman A. EP04.01-015 Lung Cancer after Solid Organ Transplantation - A Claims Data Analysis. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.427] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
6
|
Zigman M, Huber M, Kepesidis K, Voronina L, Fleischmann F, Fill E, Hermann J, Koch I, Kolben T, Schulz G, Jokisch F, Reinmuth N, Gesierich W, Behr J, Harbeck N, Reiser M, Stief C, Krausz F. 90P Infrared molecular fingerprinting: A new in vitro diagnostic platform technology for cancer detection in blood-based liquid biopsies. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
7
|
Sellmer L, Kovács J, Walter J, Kumbrink J, Neumann J, Kauffmann-Guerrero D, Kiefl R, Schneider C, Jung A, Behr J, Tufman A. 92P Exploring immune dysfunction in surgically treated early stage NSCLC. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.02.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
8
|
Sellmer L, Kovács J, Neumann J, Walter J, Kauffmann-Guerrero D, Syunyaeva Z, Fertmann J, Schneider C, Zimmermann J, Behr J, Tufman A. MA08.06 Immune Cell Profiles as Predictors of Survival in Surgically Treated Non-Small Cell Lung Cancer (NSCLC). J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.08.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
9
|
Kirsten D, de Vries U, Costabel U, Koschel D, Bonella F, Günther A, Behr J, Claussen M, Schwarz S, Prasse A, Kreuter M. [Linguistic Validation of the "German Lung Fibrosis Health Related Quality of Life Questionnaire"]. Pneumologie 2021; 75:753-760. [PMID: 34428830 DOI: 10.1055/a-1334-2745] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
UNLABELLED Health status and quality of life are impaired in patients with idiopathic pulmonary fibrosis (IPF) and idiopathic non-specific interstitial fibrosis (iNSIP). In Germany exists only the K-BILD questionnaire for patients with ILD 1 in a professional translation by Kreuter et al. 2 This questionnaire focuses on the main problems in patients with progressive lung fibrosis in a limited manner. Therefore a new quality of life questionnaire for patients with idiopathic pulmonary fibrosis was developed and linguistically validated. METHODS The linguistic validation of our questionnaire was carried out in a multistage process in collaboration with the developer of the questionnaire and bilingual, professional translators. Review by the developers and back translations as well as clinical assessment by IPF- and iNSIP-patients ensured that the translated questionnaire reflected the intention of the original English version of our questionnaire.Cross-validation was carried out with the St. Georges Respiratory Questionnaire (SGRQ). RESULTS The new questionnaire concerning the health status was composed in English and German language. The questions cover five scales (sensitivity, selectivity and symptoms like breathlessness and cough and a visual analog scale on general health status) with 23 items. CONCLUSIONS The results show that the FFB maps the special needs of the patients with IPF and iNSIP well and can support clinical and scientific questions and can be helpful in monitoring the clinical course.
Collapse
Affiliation(s)
| | - U de Vries
- Zentrum für Klinische Psychologie und Rehabilitation der Universität Bremen
| | - U Costabel
- Klinik für Pneumologie, Ruhrlandklinik, Universitätsmedizin Essen
| | | | - F Bonella
- Klinik für Pneumologie, Ruhrlandklinik, Universitätsmedizin Essen
| | - A Günther
- Medizinische Klinik Universität Gießen
| | - J Behr
- Medzinische Klinik und Poliklinik V, LMU Klinikum, Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | | | - S Schwarz
- Asklepios Klinikum Harburg, Lungenabteilung
| | - A Prasse
- Klinik für Pneumologie, Medizinische Hochschule Hannover
| | - M Kreuter
- Zentrum für interstitielle und seltene Lungenerkrankungen, Thoraxklinik, Universitätsklinikum Heidelberg und Deutsches Zentrum für Lungenforschung, Heidelberg
| |
Collapse
|
10
|
Lassau N, Bousaid I, Chouzenoux E, Lamarque J, Charmettant B, Azoulay M, Cotton F, Khalil A, Lucidarme O, Pigneur F, Benaceur Y, Sadate A, Lederlin M, Laurent F, Chassagnon G, Ernst O, Ferreti G, Diascorn Y, Brillet P, Creze M, Cassagnes L, Caramella C, Loubet A, Dallongeville A, Abassebay N, Ohana M, Banaste N, Cadi M, Behr J, Boussel L, Fournier L, Zins M, Beregi J, Luciani A, Cotten A, Meder J. Three artificial intelligence data challenges based on CT and MRI. Diagn Interv Imaging 2020; 101:783-788. [DOI: 10.1016/j.diii.2020.03.006] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/06/2020] [Accepted: 03/12/2020] [Indexed: 02/07/2023]
|
11
|
Blanc D, Racine V, Khalil A, Deloche M, Broyelle JA, Hammouamri I, Sinitambirivoutin E, Fiammante M, Verdier E, Besson T, Sadate A, Lederlin M, Laurent F, Chassagnon G, Ferretti G, Diascorn Y, Brillet PY, Cassagnes L, Caramella C, Loubet A, Abassebay N, Cuingnet P, Ohana M, Behr J, Ginzac A, Veyssiere H, Durando X, Bousaïd I, Lassau N, Brehant J. Artificial intelligence solution to classify pulmonary nodules on CT. Diagn Interv Imaging 2020; 101:803-810. [PMID: 33168496 DOI: 10.1016/j.diii.2020.10.004] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Revised: 10/12/2020] [Accepted: 10/13/2020] [Indexed: 12/20/2022]
Abstract
PURPOSE The purpose of this study was to create an algorithm to detect and classify pulmonary nodules in two categories based on their volume greater than 100 mm3 or not, using machine learning and deep learning techniques. MATERIALS AND METHOD The dataset used to train the model was provided by the organization team of the SFR (French Radiological Society) Data Challenge 2019. An asynchronous and parallel 3-stages pipeline was developed to process all the data (a data "pre-processing" stage; a "nodule detection" stage; a "classifier" stage). Lung segmentation was achieved using 3D U-NET algorithm; nodule detection was done using 3D Retina-UNET and classifier stage with a support vector machine algorithm on selected features. Performances were assessed using area under receiver operating characteristics curve (AUROC). RESULTS The pipeline showed good performance for pathological nodule detection and patient diagnosis. With the preparation dataset, an AUROC of 0.9058 (95% confidence interval [CI]: 0.8746-0.9362) was obtained, 87% yielding accuracy (95% CI: 84.83%-91.03%) for the "nodule detection" stage, corresponding to 86% specificity (95% CI: 82%-92%) and 89% sensitivity (95% CI: 84.83%-91.03%). CONCLUSION A fully functional pipeline using 3D U-NET, 3D Retina-UNET and classifier stage with a support vector machine algorithm was developed, resulting in high capabilities for pulmonary nodule classification.
Collapse
Affiliation(s)
- D Blanc
- QuantaCell, IRMB, Hôpital Saint-Eloi, 34090 Montpellier, France
| | - V Racine
- QuantaCell, IRMB, Hôpital Saint-Eloi, 34090 Montpellier, France
| | - A Khalil
- Department of Radiology, Neuroradiology unit, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat Claude Bernard, 75018 Paris, France; Université de Paris, 75010, Paris, France
| | - M Deloche
- >IBM Cognitive Systems Lab, 34000 Montpellier, France
| | - J-A Broyelle
- >IBM Cognitive Systems Lab, 34000 Montpellier, France
| | - I Hammouamri
- >IBM Cognitive Systems Lab, 34000 Montpellier, France
| | | | - M Fiammante
- IBM Cognitive Systems France, 92270 Bois-Colombes, France
| | - E Verdier
- IBM Cognitive Systems France, 92270 Bois-Colombes, France
| | - T Besson
- IBM Cognitive Systems France, 92270 Bois-Colombes, France
| | - A Sadate
- Department of Radiology and Medical Imaging, CHU Nîmes, University Montpellier, EA2415, 30029 Nîmes, France
| | - M Lederlin
- Department of Radiology, Hôpital Universitaire Pontchaillou, 35000 Rennes, France
| | - F Laurent
- Department of thoracic and cardiovascular Imaging, Respiratory Diseases Service, Respiratory Functional Exploration Service, Hôpital universitaire de Bordeaux, CIC 1401, 33600 Pessac, France
| | - G Chassagnon
- Department of Radiology, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, 75014, Paris, France & Université de Paris, 75006 Paris, France
| | - G Ferretti
- Department of Radiology and Medical Imaging, CHU Grenoble Alpes, 38700 Grenoble, France
| | - Y Diascorn
- Department of Radiology, Hôpital Universitaire Pasteur, Nice, France
| | - P-Y Brillet
- Inserm UMR 1272, Université Sorbonne Paris Nord, Assistance Publique-Hôpitaux de Paris, Department of Radiology, Hôpital Avicenne, 93430 Bobigny, France
| | - Lucie Cassagnes
- Department of radiology B, CHU Gabriel Montpied, 63003 Clermont-Ferrand, France
| | - C Caramella
- Department of Radiology, Institut Gustave Roussy, 94800 Villejuif, France
| | - A Loubet
- Department of Neuroradiology, Hôpital Gui-de-Chauliac, CHRU de Montpellier, 34000 Montpellier, France
| | - N Abassebay
- Department of Radiology, CH Douai, 59507 Douai, France
| | - P Cuingnet
- Department of Radiology, CH Douai, 59507 Douai, France
| | - M Ohana
- Department of Radiology, Nouvel Hôpital Civil, 67000 Strasbourg, France
| | - J Behr
- Department of Radiology, CHRU de Jean-Minjoz Besançon, 25030 Besançon, France
| | - A Ginzac
- Clinical Research Unit, Clinical Research and Innovation Delegation, Centre de Lutte contre le Cancer, Centre Jean Perrin, 63011 Clermont-Ferrand Cedex 1, France; Université Clermont Auvergne,INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Centre Jean Perrin, 63011 Clermont-Ferrand, France; Clinical Investigation Center, UMR501, 63011 Clermont-Ferrand, France
| | - H Veyssiere
- Clinical Research Unit, Clinical Research and Innovation Delegation, Centre de Lutte contre le Cancer, Centre Jean Perrin, 63011 Clermont-Ferrand Cedex 1, France; Université Clermont Auvergne,INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Centre Jean Perrin, 63011 Clermont-Ferrand, France; Clinical Investigation Center, UMR501, 63011 Clermont-Ferrand, France
| | - X Durando
- Clinical Research Unit, Clinical Research and Innovation Delegation, Centre de Lutte contre le Cancer, Centre Jean Perrin, 63011 Clermont-Ferrand Cedex 1, France; Université Clermont Auvergne,INSERM, U1240 Imagerie Moléculaire et Stratégies Théranostiques, Centre Jean Perrin, 63011 Clermont-Ferrand, France; Clinical Investigation Center, UMR501, 63011 Clermont-Ferrand, France; Department of Medical Oncology, Centre Jean Perrin, 63011 Clermont-Ferrand, France
| | - I Bousaïd
- Digital Transformation and Information Systems Division, Gustave Roussy, 94800 Villejuif, France
| | - N Lassau
- Multimodal Biomedical Imaging Laboratory Paris-Saclay, BIOMAPS, UMR 1281, Université Paris-Saclay, Inserm, CNRS, CEA, Department of Radiology, Institut Gustave Roussy, 94800, Villejuif, France
| | - J Brehant
- Department of Radiology, Centre Jean Perrin, 63011 Clermont-Ferrand, France.
| |
Collapse
|
12
|
Soumagne T, Winiszewski H, Besch G, Mahr N, Senot T, Costa P, Grillet F, Behr J, Mouhat B, Mourey G, Fournel A, Meneveau N, Samain E, Capellier G, Piton G, Pili-Floury S. Pulmonary embolism among critically ill patients with ARDS due to COVID-19. Respir Med Res 2020; 78:100789. [PMID: 33022510 PMCID: PMC7494436 DOI: 10.1016/j.resmer.2020.100789] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2020] [Revised: 08/25/2020] [Accepted: 08/31/2020] [Indexed: 02/06/2023]
Affiliation(s)
- T Soumagne
- Medical Intensive Care Unit, Besançon University Hospital, Besançon, France.
| | - H Winiszewski
- Medical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - G Besch
- Anaesthesiology and Surgical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - N Mahr
- Medical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - T Senot
- Anaesthesiology and Surgical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - P Costa
- Surgical and Medical Vascular Unit, Besançon University Hospital, Besançon, France
| | - F Grillet
- Department of Radiology, Besançon University Hospital, Besançon, France
| | - J Behr
- Department of Radiology, Besançon University Hospital, Besançon, France
| | - B Mouhat
- Cardiology Unit, Besançon University Hospital, Besançon, France
| | - G Mourey
- Hematology Unit, Besançon University Hospital, Besançon, France
| | - A Fournel
- Hematology Unit, Besançon University Hospital, Besançon, France
| | - N Meneveau
- Cardiology Unit, Besançon University Hospital, Besançon, France
| | - E Samain
- Anaesthesiology and Surgical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - G Capellier
- Medical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - G Piton
- Medical Intensive Care Unit, Besançon University Hospital, Besançon, France
| | - S Pili-Floury
- Anaesthesiology and Surgical Intensive Care Unit, Besançon University Hospital, Besançon, France
| |
Collapse
|
13
|
Behr J, Günther A, Bonella F, Dinkel J, Fink L, Geiser T, Geißler K, Gläser S, Handzhhiev S, Jonigk D, Koschel D, Kreuter M, Leuschner G, Markart P, Prasse A, Schönfeld N, Schupp JC, Sitter H, Müller-Quernheim J, Costabel U. [German Guideline for Idiopathic Pulmonary Fibrosis]. Pneumologie 2020; 74:e1-e2. [PMID: 32422671 DOI: 10.1055/a-1179-2905] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Mitglied des Deutschen Zentrums für Lungenforschung, München
| | - A Günther
- Schwerpunkt Fibrosierende Lungenerkrankungen, Universitätsklinikum Gießen - Marburg, Standort Gießen, Justus-Liebig-Universität Gießen, sowie Agaplesion Pneumologische Klinik Waldhof-Elgershausen, Greifenstein, University of Giessen Marburg Lung Center, Mitglied des Deutschen Zentrums für Lungenforschung
| | - F Bonella
- Zentrum für interstitielle und seltene Lungenkrankheiten, Klinik für Pneumologie, Ruhrlandklinik, Universitätsmedizin Essen, Essen
| | - J Dinkel
- Klinik für Radiologie, Klinikum der Universität München, LMU, und Asklepios Fachkliniken München Gauting, Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - L Fink
- Institut für Pathologie und Zytologie, ÜGP Wetzlar, Mitglied des Deutschen Zentrums für Lungenforschung, Wetzlar
| | - T Geiser
- Universitätsklinik für Pneumologie, Universitätsspital, Universität Bern, Bern
| | - K Geißler
- Patientenvertretung Lungenfibrose e. V., Essen
| | - S Gläser
- Vivantes Klinikum Neukölln und Spandau Berlin, Klinik für Innere Medizin - Pneumologie und Infektiologie sowie und Universitätsmedizin Greifswald, Greifswald
| | - S Handzhhiev
- Klinische Abteilung für Pneumologie, Universitätsklinikum Krems, Krems an der Donau, Österreich
| | - D Jonigk
- Institut für Pathologie, Medizinische Hochschule Hannover, Mitglied des Deutschen Zentrums für Lungenforschung, Hannover
| | - D Koschel
- Abteilung Innere Medizin/Pneumologie, Fachkrankenhaus Coswig, Zentrum für Pneumologie, Allergologie, Beatmungsmedizin, Thoraxchirurgie und Medizinische Klinik 1, Bereich Pneumologie, Universitätsklinikum Carl Gustav Carus, Dresden
| | - M Kreuter
- Zentrum für interstitielle und seltene Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Mitglied des Deutschen Zentrums für Lungenforschung, Heidelberg
| | - G Leuschner
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Mitglied des Deutschen Zentrums für Lungenforschung, München
| | - P Markart
- Schwerpunkt Fibrosierende Lungenerkrankungen, Universitätsklinikum Gießen - Marburg, Standort Gießen, Justus-Liebig-Universität Gießen, University of Giessen Marburg Lung Center, sowie Campus Fulda Universitätsmedizin Marburg, Med. Klinik V; Mitglied des Deutschen Zentrums für Lungenforschung, Fulda
| | - A Prasse
- Klinik für Pneumologie, Medizinische Hochschule Hannover und Clinical Research Center Fraunhofer Institut ITEM, Mitglied des Deutschen Zentrums für Lungenforschung, Hannover
| | - N Schönfeld
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - J C Schupp
- Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, United States
| | - H Sitter
- Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Berlin
| | - J Müller-Quernheim
- Klinik für Pneumologie, Department Innere Medizin, Medizinische Fakultät, Albert Ludwigs Universität, Freiburg
| | - U Costabel
- Zentrum für interstitielle und seltene Lungenkrankheiten, Klinik für Pneumologie, Ruhrlandklinik, Universitätsmedizin Essen, Essen
| |
Collapse
|
14
|
Behr J, Günther A, Bonella F, Dinkel J, Fink L, Geiser T, Geißler K, Gläser S, Handzhhiev S, Jonigk D, Koschel D, Kreuter M, Leuschner G, Markart P, Prasse A, Schönfeld N, Schupp JC, Sitter H, Müller-Quernheim J, Costabel U. [German Guideline for Idiopathic Pulmonary Fibrosis]. Pneumologie 2020; 74:263-293. [PMID: 32227328 DOI: 10.1055/a-1120-3531] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
Idiopathic pulmonary fibrosis (IPF) is a severe and often fatal disease. Diagnosis of IPF requires considerable expertise and experience. Since publication of the international IPF guideline in the year 2011 and Update 2018 several studies and technical advances occurred, which made a new assessment of the diagnostic process mandatory. In view of the antifibrotic drugs which have been approved for the treatment of IPF patients, the goal of this guideline is to foster early, confident and effective diagnosis of IPF. The guideline focusses on the typical clinical setting of an IPF patient and provides tools to exclude known causes of interstitial lung disease including standardised questionnaires, serologic testing and cellular analysis of bronchoalveolar lavage. High resolution computed tomography remains crucial in the diagnostic work-up. If it is necessary to obtain specimen for histology transbronchial lung cryobiopsy is the primary approach, while surgical lung biopsy is reserved for patients who are fit for it and in whom bronchoscopic diagnosis did not provide the information needed. Despite considerable progress, IPF remains a diagnosis of exclusion and multidisciplinary discussion remains the golden standard of diagnosis.
Collapse
Affiliation(s)
- J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Mitglied des Deutschen Zentrums für Lungenforschung, München
| | - A Günther
- Schwerpunkt Fibrosierende Lungenerkrankungen, Universitätsklinikum Gießen - Marburg, Standort Gießen, Justus-Liebig-Universität Gießen, sowie Agaplesion Pneumologische Klinik Waldhof-Elgershausen, Greifenstein, University of Giessen Marburg Lung Center, Mitglied des Deutschen Zentrums für Lungenforschung
| | - F Bonella
- Zentrum für interstitielle und seltene Lungenkrankheiten, Klinik für Pneumologie, Ruhrlandklinik, Universitätsmedizin Essen, Essen
| | - J Dinkel
- Klinik für Radiologie, Klinikum der Universität München, LMU, und Asklepios Fachkliniken München Gauting, Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - L Fink
- Institut für Pathologie und Zytologie, ÜGP Wetzlar, Mitglied des Deutschen Zentrums für Lungenforschung, Wetzlar
| | - T Geiser
- Universitätsklinik für Pneumologie, Universitätsspital, Universität Bern, Bern
| | - K Geißler
- Patientenvertretung Lungenfibrose e. V., Essen
| | - S Gläser
- Vivantes Klinikum Neukölln und Spandau Berlin, Klinik für Innere Medizin - Pneumologie und Infektiologie sowie und Universitätsmedizin Greifswald, Greifswald
| | - S Handzhhiev
- Klinische Abteilung für Pneumologie, Universitätsklinikum Krems, Krems an der Donau, Österreich
| | - D Jonigk
- Institut für Pathologie, Medizinische Hochschule Hannover, Mitglied des Deutschen Zentrums für Lungenforschung, Hannover
| | - D Koschel
- Abteilung Innere Medizin/Pneumologie, Fachkrankenhaus Coswig, Zentrum für Pneumologie, Allergologie, Beatmungsmedizin, Thoraxchirurgie und Medizinische Klinik 1, Bereich Pneumologie, Universitätsklinikum Carl Gustav Carus, Dresden
| | - M Kreuter
- Zentrum für interstitielle und seltene Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Mitglied des Deutschen Zentrums für Lungenforschung, Heidelberg
| | - G Leuschner
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center, Mitglied des Deutschen Zentrums für Lungenforschung, München
| | - P Markart
- Schwerpunkt Fibrosierende Lungenerkrankungen, Universitätsklinikum Gießen - Marburg, Standort Gießen, Justus-Liebig-Universität Gießen, University of Giessen Marburg Lung Center, sowie Campus Fulda Universitätsmedizin Marburg, Med. Klinik V; Mitglied des Deutschen Zentrums für Lungenforschung, Fulda
| | - A Prasse
- Klinik für Pneumologie, Medizinische Hochschule Hannover und Clinical Research Center Fraunhofer Institut ITEM, Mitglied des Deutschen Zentrums für Lungenforschung, Hannover
| | - N Schönfeld
- Klinik für Pneumologie, Lungenklinik Heckeshorn, Helios Klinikum Emil von Behring, Berlin
| | - J C Schupp
- Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, Yale University, New Haven, Connecticut, United States
| | - H Sitter
- Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Berlin
| | - J Müller-Quernheim
- Klinik für Pneumologie, Department Innere Medizin, Medizinische Fakultät, Albert Ludwigs Universität, Freiburg
| | - U Costabel
- Zentrum für interstitielle und seltene Lungenkrankheiten, Klinik für Pneumologie, Ruhrlandklinik, Universitätsmedizin Essen, Essen
| |
Collapse
|
15
|
Kahnert K, Föhrenbach M, Lucke T, Alter P, Trudzinski FT, Bals R, Lutter JI, Timmermann H, Söhler S, Förderreuther S, Nowak D, Watz H, Waschki B, Behr J, Welte T, Vogelmeier CF, Jörres RA. The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET. Respir Res 2020; 21:28. [PMID: 31959163 PMCID: PMC6971882 DOI: 10.1186/s12931-020-1293-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Accepted: 01/14/2020] [Indexed: 11/10/2022] Open
Abstract
Background Peripheral neuropathy is a common comorbidity in COPD. We aimed to investigate associations between alterations commonly found in COPD and peripheral neuropathy, with particular emphasize on the distinction between direct and indirect effects. Methods We used visit 4 data of the COPD cohort COSYCONET, which included indicators of polyneuropathy (repeated tuning fork and monofilament testing), excluding patients with diabetes a/o increased HbA1c. These indicators were analysed for the association with COPD characteristics, including lung function, blood gases, 6-min walk distance (6-MWD), timed-up-and-go-test (TUG), exacerbation risk according to GOLD, C-reactive protein (CRP), and ankle-brachial index (ABI). Based on the results of conventional regression analyses adjusted for age, BMI, packyears and gender, we utilized structural equation modelling (SEM) to quantify the network of direct and indirect relationships between parameters. Results 606 patients were eligible for analysis. The indices of polyneuropathy were highly correlated with each other and related to base excess (BE), ABI and TUG. ABI was linked to neuropathy and 6-MWD, exacerbations depended on FEV1, 6-MWD and CRP. The associations could be summarized into a SEM comprising polyneuropathy as a latent variable (PNP) with three measured indicator variables. Importantly, PNP was directly dependent on ABI and particularly on BE. When also including patients with diabetes and/or elevated values of HbA1c (n = 742) the SEM remained virtually the same. Conclusion We identified BE and ABI as major determinants of peripheral neuropathy in patients with COPD. All other associations, particularly those with lung function and physical capacity, were indirect. These findings underline the importance of alterations of the micromilieu in COPD, in particular the degree of metabolic compensation and vascular status.
Collapse
Affiliation(s)
- K Kahnert
- Department of Internal Medicine V - Pulmonology, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich (CPC-M, member of German Center for Lung Research (DZL), Marchioninisr. 15, 81377 München, and Ziemssenstr. 1, 80336, Munich, Germany.
| | - M Föhrenbach
- Institute and Clinic for Occupational, Social and Environmental Medicine, Comprehensive Pneumology Center Munich (CPC-M, member of German Center for Lung Research (DZL), University Hospital, LMU Munich, Ziemssenstr. 1, 80336, Munich, Germany
| | - T Lucke
- Institute and Clinic for Occupational, Social and Environmental Medicine, Comprehensive Pneumology Center Munich (CPC-M, member of German Center for Lung Research (DZL), University Hospital, LMU Munich, Ziemssenstr. 1, 80336, Munich, Germany
| | - P Alter
- Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Germany, Member of the German Center for Lung Research (DZL), Baldingerstrasse, 35043, Marburg, Germany.,Department of Internal Medicine V - Pulmonology, Allergology, Intensive Care Medicine, Saarland University Hospital, Kirrberger Straße 1, 66424, Homburg, Germany
| | - F T Trudzinski
- Department of Internal Medicine V - Pulmonology, Allergology, Intensive Care Medicine, Saarland University Hospital, Kirrberger Straße 1, 66424, Homburg, Germany
| | - R Bals
- Department of Internal Medicine V - Pulmonology, Allergology, Intensive Care Medicine, Saarland University Hospital, Kirrberger Straße 1, 66424, Homburg, Germany
| | - J I Lutter
- Institute of Health Economics and Health Care Management, Helmholtz Zentrum München GmbH - German Research Center for Environmental Health, Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research, Ingolstädter Landstr. 1, 85764, Munich, Germany
| | - H Timmermann
- Hamburger Institut für Therapieforschung GmbH, Colonaden 72, 20354, Hamburg, Germany
| | - S Söhler
- ASCONET Study Coordination Office, University of Marburg, Baldingerstraße, 35043, Marburg, Germany
| | - S Förderreuther
- Department of Neurology, Klinikum Innenstadt, Ludwig Maximilian University of Munich, Ziemssenstr. 1, 80336, Munich, Germany
| | - D Nowak
- Institute and Clinic for Occupational, Social and Environmental Medicine, Comprehensive Pneumology Center Munich (CPC-M, member of German Center for Lung Research (DZL), University Hospital, LMU Munich, Ziemssenstr. 1, 80336, Munich, Germany
| | - H Watz
- Institute and Clinic for Occupational, Social and Environmental Medicine, Comprehensive Pneumology Center Munich (CPC-M, member of German Center for Lung Research (DZL), University Hospital, LMU Munich, Ziemssenstr. 1, 80336, Munich, Germany
| | - B Waschki
- LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.,Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany
| | - J Behr
- Department of Internal Medicine V - Pulmonology, University Hospital, LMU Munich, Comprehensive Pneumology Center Munich (CPC-M, member of German Center for Lung Research (DZL), Marchioninisr. 15, 81377 München, and Ziemssenstr. 1, 80336, Munich, Germany
| | - T Welte
- Department of Pneumology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany
| | - C F Vogelmeier
- Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Germany, Member of the German Center for Lung Research (DZL), Baldingerstrasse, 35043, Marburg, Germany
| | - R A Jörres
- Institute and Clinic for Occupational, Social and Environmental Medicine, Comprehensive Pneumology Center Munich (CPC-M, member of German Center for Lung Research (DZL), University Hospital, LMU Munich, Ziemssenstr. 1, 80336, Munich, Germany
| |
Collapse
|
16
|
Ceri T, Podda A, Behr J, Brumpt E, Alilet M, Aubry S. Posterior interosseous nerve of the elbow at the arcade of Frohse: Ultrasound appearance in asymptomatic subjects. Diagn Interv Imaging 2019; 100:521-525. [DOI: 10.1016/j.diii.2019.03.007] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2018] [Revised: 02/07/2019] [Accepted: 03/05/2019] [Indexed: 10/27/2022]
|
17
|
Schiopu S, Zacherl M, Todica A, Milger K, Behr J, Neurohr C, Huber B, Kneidinger N. P290SPECT myocardial perfusion imaging using regadenoson in end-stage lung disease: clearing the air and giving an answer. Eur Heart J Cardiovasc Imaging 2019. [DOI: 10.1093/ehjci/jez148.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- S Schiopu
- Ludwig-Maximilians University, Medical Clinic V, Grosshadern, Munich, Germany
| | - M Zacherl
- Ludwig-Maximilians University, Nuclear Medicine, Munich, Germany
| | - A Todica
- Ludwig-Maximilians University, Nuclear Medicine, Munich, Germany
| | - K Milger
- Ludwig-Maximilians University, Medical Clinic V, Grosshadern, Munich, Germany
| | - J Behr
- Ludwig-Maximilians University, Medical Clinic V, Grosshadern, Munich, Germany
| | - C Neurohr
- Robert Bosch Hospital, Pneumonolie und Beatmungsmedizin, Stuttgart, Germany
| | - B Huber
- Ludwig-Maximilians University, Medical Clinic I, Munich, Germany
| | - N Kneidinger
- Ludwig-Maximilians University, Medical Clinic V, Grosshadern, Munich, Germany
| |
Collapse
|
18
|
Hilgarth M, Lehner E, Behr J, Vogel R. Diversity and anaerobic growth ofPseudomonasspp. isolated from modified atmosphere packaged minced beef. J Appl Microbiol 2019; 127:159-174. [DOI: 10.1111/jam.14249] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2018] [Revised: 03/07/2019] [Accepted: 03/08/2019] [Indexed: 11/29/2022]
Affiliation(s)
- M. Hilgarth
- Lehrstuhl für Technische Mikrobiologie Technische Universität München Freising Germany
| | - E.M. Lehner
- Lehrstuhl für Technische Mikrobiologie Technische Universität München Freising Germany
| | - J. Behr
- Lehrstuhl für Technische Mikrobiologie Technische Universität München Freising Germany
| | - R.F. Vogel
- Lehrstuhl für Technische Mikrobiologie Technische Universität München Freising Germany
| |
Collapse
|
19
|
Lassau N, Estienne T, de Vomecourt P, Azoulay M, Cagnol J, Garcia G, Majer M, Jehanno E, Renard-Penna R, Balleyguier C, Bidault F, Caramella C, Jacques T, Dubrulle F, Behr J, Poussange N, Bocquet J, Montagne S, Cornelis F, Faruch M, Bresson B, Brunelle S, Jalaguier-Coudray A, Amoretti N, Blum A, Paisant A, Herreros V, Rouviere O, Si-Mohamed S, Di Marco L, Hauger O, Garetier M, Pigneur F, Bergère A, Cyteval C, Fournier L, Malhaire C, Drape JL, Poncelet E, Bordonne C, Cauliez H, Budzik JF, Boisserie M, Willaume T, Molière S, Peyron Faure N, Caius Giurca S, Juhan V, Caramella T, Perrey A, Desmots F, Faivre-Pierre M, Abitbol M, Lotte R, Istrati D, Guenoun D, Luciani A, Zins M, Meder JF, Cotten A. Five simultaneous artificial intelligence data challenges on ultrasound, CT, and MRI. Diagn Interv Imaging 2019; 100:199-209. [DOI: 10.1016/j.diii.2019.02.001] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2019] [Accepted: 02/04/2019] [Indexed: 12/18/2022]
|
20
|
Couteaux V, Si-Mohamed S, Renard-Penna R, Nempont O, Lefevre T, Popoff A, Pizaine G, Villain N, Bloch I, Behr J, Bellin MF, Roy C, Rouvière O, Montagne S, Lassau N, Boussel L. Kidney cortex segmentation in 2D CT with U-Nets ensemble aggregation. Diagn Interv Imaging 2019; 100:211-217. [DOI: 10.1016/j.diii.2019.03.001] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2019] [Revised: 03/06/2019] [Accepted: 03/06/2019] [Indexed: 10/27/2022]
|
21
|
Kolbeck S, Behr J, Vogel RF, Ludwig C, Ehrmann MA. Acid stress response ofStaphylococcus xylosuselicits changes in the proteome and cellular membrane. J Appl Microbiol 2019; 126:1480-1495. [DOI: 10.1111/jam.14224] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Revised: 01/29/2019] [Accepted: 02/11/2019] [Indexed: 01/05/2023]
Affiliation(s)
- S. Kolbeck
- Lehrstuhl für Technische Mikrobiologie Technische Universität München Freising Germany
| | - J. Behr
- Leibniz‐Institut für Lebensmittel‐Systembiologie Technische Universität München Freising Germany
| | - R. F. Vogel
- Lehrstuhl für Technische Mikrobiologie Technische Universität München Freising Germany
| | - C. Ludwig
- Bayrisches Zentrum für biomolekulare Massenspektrometrie (BayBioMS) Freising Germany
| | - M. A. Ehrmann
- Lehrstuhl für Technische Mikrobiologie Technische Universität München Freising Germany
| |
Collapse
|
22
|
Hamam J, Grillet F, Guillien A, Manzoni P, Behr J, Dalphin J. SPOT : Score prédictif de Pneumothorax secondaires aux pOnction-biopsies Transthoraciques pulmonaires scanno-guidées. Étude rétrospective. Rev Mal Respir 2019. [DOI: 10.1016/j.rmr.2018.10.150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
23
|
Jouneau S, Kolb M, Wells A, Behr J, Richeldi L, Schnaidt S, Quaresma M, Stowasser S, Raghu G, Martinez J. INSTAGE : essai randomisé du nintédanib plus sildénafil versus nintédanib seul chez des patients présentant une fibrose pulmonaire idiopathique (FPI) et une altération avancée de la fonction pulmonaire. Rev Mal Respir 2019. [DOI: 10.1016/j.rmr.2018.10.291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
24
|
Götschke J, Mertsch P, Bischof M, Kneidinger N, Matthes S, Renner E, Schultz K, Traidl-Hoffmann C, Duchna HW, Behr J, Schmude J, Huber RM, Milger K. Perception of climate change in patients with chronic lung disease. Pneumologie 2018. [DOI: 10.1055/s-0037-1619415] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- J Götschke
- Medizinische Klinik V, Klinikum der Universität München
| | - P Mertsch
- Medizinische Klinik V, Klinikum der Universität München
| | - M Bischof
- Wirtschaftsgeografie und Tourismusforschung, Universität München
| | - N Kneidinger
- Medizinische Klinik V, Klinikum der Universität München
| | - S Matthes
- Medizinische Klinik V, Klinikum der Universität München
| | - E Renner
- Christine Kühne – Center for Allergy Research and Education, CK-Care, Davos
| | | | - C Traidl-Hoffmann
- Chair and Institute of Environmental Medicine, Unika-T, Technical University Munich and Helmholtz Zentrum München; German Research Center for Environmental Health, Augsburg
| | | | - J Behr
- Medizinische Klinik V, Klinikum der Universität München
| | - J Schmude
- Wirtschaftsgeografie und Tourismusforschung, Universität München
| | - RM Huber
- Medizinische Klinik V, Klinikum der Universität München
| | - K Milger
- Medizinische Klinik V, Klinikum der Universität München
| |
Collapse
|
25
|
Kreuter M, Ochmann U, Koschel D, Behr J, Bonella F, Claussen M, Costabel U, Jungmann S, Kolb M, Nowak D, Petermann F, Pfeifer M, Prasse A, Schreiber J, Wälscher J, Wirtz H, Kirsten D. Fragebogen der Sektion 7 der DGP zur Erfassung der Ursachen interstitieller und seltener Lungenerkrankungen. Pneumologie 2018. [DOI: 10.1055/s-0037-1619188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- M Kreuter
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik; Universitätsklinikum Heidelberg und Translationales Zentrum für Lungenforschung Heidelberg (TLRC); Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - U Ochmann
- Institut für Arbeits-, Sozial- und Umweltmedizin; Klinikum der LMU-Universität München
| | - D Koschel
- Zentrum für Pneumologie-, Thorax- und Gefäßchirurgie, Fachkrankenhaus Coswig
| | | | | | | | | | | | - M Kolb
- Mcmaster University, Hamilton, Canada
| | - D Nowak
- Comprehensive Pneumology Center, Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin; Klinikum der LMU München
| | - F Petermann
- Zentrum für Klinische Psychologie und Rehabilitation der Universität Bremen
| | - M Pfeifer
- Klinik Donaustauf und Universitätsklinikum Regensburg
| | - A Prasse
- Klinik für Pneumologie, Medizinische Hochschule, Hannover
| | - J Schreiber
- Fachbereich Pneumologie, Universitätsklinikum Magedeburg A. ö. R
| | - J Wälscher
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Thoraxklinik, Uniklinikum Heidelberg
| | - H Wirtz
- Pneumologie, Universitätsklinikum der Universität Leipzig
| | - D Kirsten
- Airway Research Center North (Arcn), Lungenclinic Grosshansdorf; Member of the German Center for Lung Research (DZL)
| |
Collapse
|
26
|
Knoop H, Behr J, Bonella F, Knoop U. Therapeutisches Vorgehen bei IPAF? Pneumologie 2018. [DOI: 10.1055/s-0037-1619329] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- H Knoop
- Gemeinschaftspraxis Dr. med. Umut Knoop und Dr. med. Heiko Knoop
| | - J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der LMU München; Comprehensive Pneumology Center
| | - F Bonella
- Schwerpunkt Interstitielle und Seltene Lungenerkrankungen, Ruhrlandklinik, Universitätsmedizin Essen
| | - U Knoop
- Gemeinschaftspraxis Dr. med. Umut Knoop und Dr. med. Heiko Knoop
| |
Collapse
|
27
|
Polke M, Behr J, Kabitz H, Neurohr C, Leuschner G, Prasse A, Bonella F, Koschel D, Günther A, Wälscher J, Herth FJF, Kreuter M. Status zur Diagnostik und Therapie der akuten Exazerbation der idiopathischen Lungenfibrose in Deutschland – ein weites Feld! Pneumologie 2018. [DOI: 10.1055/s-0037-1619401] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- M Polke
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - J Behr
- Klinik für Pneumologie, Asklepios Fachklinik München-Gauting; Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Großhadern; Schwerpunkt Pneumologie, Klinikum Großhadern der LMU; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - H Kabitz
- II. Medizinische Klinik, Pneumologie, Kardiologie, Internistische Intensivmedizin, Klinikum Konstanz
| | - C Neurohr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Großhadern; Schwerpunkt Pneumologie, Klinikum Großhadern der LMU; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - G Leuschner
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Großhadern; Schwerpunkt Pneumologie, Klinikum Großhadern der LMU; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - A Prasse
- Klinik für Pneumologie, Medizinische Hochschule Hannover; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - F Bonella
- Schwerpunkt Interstitielle und Seltene Lungenkrankheiten, Ruhrlandklinik, Universitätsmedizin Essen
| | - D Koschel
- Zentrum für Pneumologie, Thorax- und Gefäßchirurgie, Fachkrankenhaus Coswig GmbH
| | - A Günther
- Med. Klinik II, Klinische Forschergruppe 'Lungenfibrose', Universitätsklinikum Gießen und Marburg; Lungenfachklinik Waldhof-Elgershausen, Greifenstein; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - J Wälscher
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - FJF Herth
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - M Kreuter
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| |
Collapse
|
28
|
Götschke J, Mertsch P, Kneidinger N, Kauffmann-Guerrero D, Behr J, Huber RM, Reichenberger F, Milger K. Daily chronic intermittend hypobaric hypoxia does not induce chronic increase in pulmonary arterial pressure. Pneumologie 2018. [DOI: 10.1055/s-0037-1619327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- J Götschke
- Medizinische Klinik V, Comprehensive Pneumology Center (Cpc-M), Mitglied des Dzl, Klinikum der Universität München
| | - P Mertsch
- Medizinische Klinik V, Comprehensive Pneumology Center (Cpc-M), Mitglied des Dzl, Klinikum der Universität München
| | - N Kneidinger
- Medizinische Klinik V, Comprehensive Pneumology Center (Cpc-M), Mitglied des Dzl, Klinikum der Universität München
| | - D Kauffmann-Guerrero
- Medizinische Klinik V, Comprehensive Pneumology Center (Cpc-M), Mitglied des Dzl, Klinikum der Universität München
| | - J Behr
- Medizinische Klinik V, Comprehensive Pneumology Center (Cpc-M), Mitglied des Dzl, Klinikum der Universität München; Asklepios Klinik Gauting
| | - RM Huber
- Medizinische Klinik V, Comprehensive Pneumology Center (Cpc-M), Mitglied des Dzl, Klinikum der Universität München
| | | | - K Milger
- Medizinische Klinik V, Comprehensive Pneumology Center (Cpc-M), Mitglied des Dzl, Klinikum der Universität München
| |
Collapse
|
29
|
Leuschner G, Veit T, Barnikel M, Crispin A, Brust J, Ceelen F, Kneidinger N, Behr J, Neurohr C. Intensiviertes Monitoring mit täglicher Heimspirometrie und Aktivitätsmessung bei interstitiellen Lungenerkrankungen. Pneumologie 2018. [DOI: 10.1055/s-0037-1619183] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- G Leuschner
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München; Mitglied des Deutschen Zentrums für Lungenforschung (DZLl)
| | - T Veit
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München; Mitglied des Deutschen Zentrums für Lungenforschung (DZLl)
| | - M Barnikel
- Medizinische Klinik und Poliklinik V, Klinikum Großhadern
| | - A Crispin
- Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilian University Munich
| | - J Brust
- Medizinische Klinik und Poliklinik V, Klinikum Großhadern
| | - F Ceelen
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München; Mitglied des Deutschen Zentrums für Lungenforschung (DZLl)
| | - N Kneidinger
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München; Mitglied des Deutschen Zentrums für Lungenforschung (DZLl)
| | - J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der LMU München; Comprehensive Pneumology Center
| | - C Neurohr
- Schwerpunkt Pneumologie, Medizinische Klinik und Poliklinik V, Klinikum der LMU München, Großhadern
| |
Collapse
|
30
|
Behr J, Noth I, Wijsenbeek MS, Kolb M, Bonella F, Moros L, Wachtlin D, Corte TJ. Cardiovascular safety of nintedanib in subgroups by cardiovascular risk at baseline in the TOMORROW and INPULSIS trials. Pneumologie 2018. [DOI: 10.1055/s-0037-1619236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- J Behr
- Medizinische Klinik und Poliklinik V, LMU und Asklepios Lungenfachkliniken München-Gauting
| | - I Noth
- Pulmonary and Critical Care Medicine, University of Chicago, Illinois
| | | | - M Kolb
- Mcmaster University, Hamilton, Ontario
| | - F Bonella
- Interstitial and Rare Lung Disease Unit, Ruhrlandklinik, University Hospital, University of Duisburg-Essen
| | - L Moros
- Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein
| | - D Wachtlin
- Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein
| | - TJ Corte
- Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia and University of Sydney
| |
Collapse
|
31
|
Kreuter M, Herth FJF, Wacker M, Witt S, Kabitz HJ, Hagmeyer L, Hammerl P, Esselmann A, Wiederholf C, Skowasch D, Stolpe C, Joest M, Veitshans S, Leidl R, Hellmann A, Pfeifer M, Behr J, Kauschka D, Mall M, Günther A, Markart P. Diagnostik und Therapie von Patienten mit interstitiellen Lungenerkrankungen in Deutschland – das EXCITING ILD Register. Pneumologie 2018. [DOI: 10.1055/s-0037-1619191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- M Kreuter
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik; Universitätsklinikum Heidelberg und Translationales Zentrum für Lungenforschung Heidelberg (TLRC); Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - FJF Herth
- Centre for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Critical Care Medicine, Thoraxklinik, University of Heidelberg
| | - M Wacker
- Institute of Health Economics and Healthcare Management, Helmholtz Centre Munich GmbH, German Research Centre for Environmental Health, Member of the German Centre for Lung Research (DZL), Comprehensive Pneumology Centre Munich (CPC-M)
| | - S Witt
- Institute of Health Economics and Healthcare Management, Helmholtz Centre Munich GmbH, German Research Centre for Environmental Health, Member of the German Centre for Lung Research (DZL), Comprehensive Pneumology Centre Munich (CPC-M)
| | | | - L Hagmeyer
- Clinic of Pneumology and Allergology, Center of Sleep Medicine and Respiratory Care, Hospital Bethanien Solingen
| | | | - A Esselmann
- Outpatient Center for Pulmonology, Warendorf
| | | | - D Skowasch
- Medical Clinic II, University Hospital Bonn
| | - C Stolpe
- Outpatient Center for Pulmonology, Ibbenbüren
| | - M Joest
- Malteser Center for Pulmonology and Allergology, Bonn
| | - S Veitshans
- Outpatient Center for Pulmonology, Böblingen
| | - R Leidl
- Institute of Health Economics and Healthcare Management, Helmholtz Centre Munich GmbH, German Research Centre for Environmental Health, Member of the German Centre for Lung Research (DZL), Comprehensive Pneumology Centre Munich (CPC-M)
| | - A Hellmann
- Outpatient Center for Pulmonology, Augsburg
| | - M Pfeifer
- Klinik Donaustauf und Universitätsklinikum Regensburg
| | | | | | - M Mall
- Translational Pulmonology, University of Heidelberg, Germany, Member of the German Center for Lung Research (TLRC)
| | - A Günther
- Universitätsklinikum Gießen und Marburg
| | - P Markart
- Medical Clinic II, University Hospital Gießen, Universities of Gießen and Marburg Lung Centre (Ugmlc), Member and Medical Clinic V (Pneumology), Cardiothoracic Centre, Campus Fulda, University Medicine Marburg
| |
Collapse
|
32
|
Syunyaeva Z, Kahnert K, Kauffmann-Guerrero D, Mertsch P, Behr J, Huber RM. Langanhaltende Remission unter Afatinib bei NSCLC mit seltener Exon 18 EGFR-Mutation. Pneumologie 2018. [DOI: 10.1055/s-0037-1619264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- Z Syunyaeva
- Sektion Pneumologie und Thorakale Onkologie, Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Lungentumorzentrum München
| | - K Kahnert
- Medizinische Klinik V, Klinikum der Universität München LMU
| | - D Kauffmann-Guerrero
- Sektion Pneumologie und Thorakale Onkologie, Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Lungentumorzentrum München
| | - P Mertsch
- Sektion Pneumologie und Thorakale Onkologie, Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Lungentumorzentrum München
| | - J Behr
- Comprehensive Pneumology Center, Medizinische Klinik und Poliklinik V, Klinikum der LMU München
| | - RM Huber
- Sektion Pneumologie und Thorakale Onkologie, Medizinische Klinik und Poliklinik V, Klinikum der Universität München und Lungentumorzentrum München
| |
Collapse
|
33
|
Herpich J, Gesierich W, Morresi-Hauf A, Behr J, Reichenberger F. Komplikationen nach transbronchialer Krypobiospie bei fibrosierenden Lungenparenchymerkrankungen. Pneumologie 2018. [DOI: 10.1055/s-0037-1619247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- J Herpich
- Klinik für Pneumologie, Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center Munich; Mitglied Im Deutschen Zentrum für Lungenforschung (DZL)
| | - W Gesierich
- Klinik für Pneumologie, Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center Munich; Mitglied Im Deutschen Zentrum für Lungenforschung (DZL)
| | | | - J Behr
- Klinik für Pneumologie, Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center Munich; Mitglied Im Deutschen Zentrum für Lungenforschung (DZL)
| | - F Reichenberger
- Klinik für Pneumologie, Asklepios Fachkliniken München-Gauting, Comprehensive Pneumology Center Munich; Mitglied Im Deutschen Zentrum für Lungenforschung (DZL)
| |
Collapse
|
34
|
Kahnert K, Alter P, Young D, Lucke T, Heinrich J, Huber RM, Behr J, Wacker M, Biertz F, Watz H, Bals R, Welte T, Wirtz H, Herth FJF, Vestbo J, Wouters EFM, Vogelmeier C, Jörres RA. The revised GOLD 2017 COPD categorization in relation to comorbidities. Pneumologie 2018. [DOI: 10.1055/s-0037-1619396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- K Kahnert
- Medizinische Klinik V, Klinikum der Universität München LMU
| | - P Alter
- Innere Medizin, Schwerpunkt Pneumologie, Universitätsklinikum Gießen und Marburg, Standort Marburg
| | - D Young
- David Young Communications, Horsham, UK
| | - T Lucke
- Klinikum der Universität München
| | - J Heinrich
- Institut für Epidemiologie I, Helmholtz Zentrum München – Deutsches Forschungszentrum für Gesundheit und Umwelt; Comprehensive Pneumology Center Munich (CPC-M), Mitglied des Deutschen Zentrums für Lungenforschung (DZL); German Research Center for Environmental Health
| | - RM Huber
- Division of Respiratory Medicine and Thoracic Oncology, Department of Internal Medicine V, Ludwig Maximilian University of Munich and Thoracic Oncology Centre
| | - J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der LMU München, Comprehensive Pneumology Center
| | - M Wacker
- Institut für Gesundheitsökonomie und Management im Gesundheitswesen, Helmholtz Zentrum München; Comprehensive Pneumology Center Munich (CPC-M), Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - F Biertz
- Institut für Biometrie, Medizinische Hochschule Hannover
| | - H Watz
- Pneumologisches Forschungsinstitut an der Lungenclinic Grosshansdorf
| | - R Bals
- Klinik für Innere Medizin V, Universitätsklinikum des Saarlandes, Homburg
| | - T Welte
- Klinik für Pneumologie, Medizinische Hochschule Hannover
| | - H Wirtz
- Pneumologie, Universitätsklinikum der Universität Leipzig
| | - FJF Herth
- Pneumology, Institute of Internal Medicine III, Thoraxklinik, University Hospital Heidelberg
| | - J Vestbo
- Respiratory Research Group, Manchester Academic Health Sciences Centre
| | | | - C Vogelmeier
- Pulmonary and Critical Care Medicine, Department of Medicine, University Medical Centre Gießen and Marburg, Phillips-University Marburg, Member of the German Centre for Lung Research (DZL)
| | - RA Jörres
- Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin, Klinikum der LMU München
| |
Collapse
|
35
|
Kreuter M, Swigris J, Pittrow D, Geier S, Klotsche J, Prasse A, Wirtz H, Koschel D, Andreas S, Grohe C, Wilkens H, Hagmeyer L, Skowasch D, Meyer FJ, Kirschner J, Gläser S, Herth FJF, Welte T, Neurohr C, Schweiblmair M, Held M, Bahmer T, Frankenberger M, Behr J. Quality of life trajectory in patients with idiopathic pulmonary fibrosis (IPF): longitudinal QoL assessment of the INSIGHTS-IPF registry. Pneumologie 2018. [DOI: 10.1055/s-0037-1619192] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- M Kreuter
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik; Universitätsklinikum Heidelberg und Translationales Zentrum für Lungenforschung Heidelberg (TLRC); Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - J Swigris
- Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado, USA
| | - D Pittrow
- Institut für Klinische Pharmakologie, Medizinische Fakultät, Technische Universität Dresden
| | - S Geier
- Department Market Access, Boehringer Ingelheim
| | - J Klotsche
- Epidemiologie, Deutsches Rheuma-Forschungsinstitut, Berlin
| | - A Prasse
- Klinik für Pneumologie, Medizinische Hochschule, Hannover
| | - H Wirtz
- Pneumologie, Universitätsklinikum der Universität Leipzig
| | - D Koschel
- Zentrum für Pneumologie-, Thorax- und Gefäßchirurgie, Fachkrankenhaus Coswig
| | - S Andreas
- Kardiologie und Pneumologie, Lungenfachklinik Immenhausen und Universitätsmedizin Göttingen
| | - C Grohe
- Klinik für Pneumologie, ELK, Berlin Buch
| | - H Wilkens
- Pneumologie, Klinik für Innere Medizin V, Universitätsklinikum des Saarlandes, Homburg
| | | | - D Skowasch
- Medical Clinic II, University Hospital Bonn
| | - FJ Meyer
- Lungenzentrum München, LZM Bogenhausen-Harlaching, Städtisches Klinikum München GmbH
| | - J Kirschner
- Center for Internal Medical Studies Cims, Bamberg
| | - S Gläser
- Klinik und Poliklinik für Innere Medizin B, Forschungsbereich Pneumologie und Pneumologische Epidemiologie, Universitätsmedizin Greifswald; Klinik für Innere Medizin – Pneumologie, Greifswald and Vivantes Klinikum Spandau/Berlin
| | - FJF Herth
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Thoraxklinik, Uniklinikum Heidelberg
| | - T Welte
- Klinik für Pneumologie, Medizinische Hochschule Hannover
| | - C Neurohr
- Comprehensive Pneumology Center, Lungenforschungsambulanz, Klinikum der Universität München
| | | | - M Held
- Abteilung Innere Medizin, Pneumologie, Standort Missioklinik, Klinikum Würzburg Mitte
| | | | - M Frankenberger
- Comprehensive Pneumology Center, Lungenforschungsambulanz, Klinikum der Universität München
| | - J Behr
- Comprehensive Pneumology Center, Lungenforschungsambulanz, Klinikum der Universität München and Asklepios Fachkliniken München-Gauting; Member of the German Center for Lung Research (DZL)
| |
Collapse
|
36
|
Leuschner G, Reiter F, Stocker F, Crispin A, Kneidinger N, Veit T, Klenner F, Ceelen F, Zimmermann G, Leuchte H, Reu S, Dinkel J, Behr J, Neurohr C. Idiopathische Lungenfibrose bei jungen Patienten – ernstzunehmend und nicht so selten. Pneumologie 2018. [DOI: 10.1055/s-0037-1619240] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- G Leuschner
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - F Reiter
- Medizinische Klinik und Polikinik V, Klinikum Großhadern
| | - F Stocker
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - A Crispin
- Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilian University Munich
| | - N Kneidinger
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - T Veit
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - F Klenner
- Medizinische Klinik und Polikinik V, Klinikum Großhadern
| | - F Ceelen
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München; Mitglied des Deutschen Zentrums für Lungenforschung (DZL)
| | - G Zimmermann
- Pneumologie, Medizinische Klinik und Poliklinik I; Klinikum Großhadern der Ludwig-Maximilians-Universität München
| | | | - S Reu
- Institute of Pathology, Ludwig Maximilian University of Munich
| | - J Dinkel
- Institut für Klinische Radiologie; Klinikum der Universität München
| | - J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der LMU München; Comprehensive Pneumology Center
| | - C Neurohr
- Medizinische Klinik und Poliklinik V, Schwerpunkt Pneumologie, Klinikum der Universität München, Großhadern
| |
Collapse
|
37
|
Preisendoerfer S, Knüppel L, Binzenhöfer L, Fernandez IE, Juan-Guardela BM, Hatz R, Behr J, Kaminski N, Schepers A, Eickelberg O, Staab-Weijnitz C. Fk506-binding protein 11, a plasma cell-specific protein folding catalyst, is increased in pulmonary fibrosis. Pneumologie 2018. [DOI: 10.1055/s-0037-1619433] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- S Preisendoerfer
- Comprehensive Pneumology Center, Helmholtz-Zentrum München, Member of the German Center of Lung Research (DZL)
| | - L Knüppel
- Comprehensive Pneumology Center, Helmholtz-Zentrum München, Member of the German Center of Lung Research (DZL)
| | - L Binzenhöfer
- Comprehensive Pneumology Center, Helmholtz-Zentrum München, Member of the German Center of Lung Research (DZL)
| | - IE Fernandez
- Comprehensive Pneumology Center, Helmholtz-Zentrum München, Member of the German Center of Lung Research (DZL)
| | - BM Juan-Guardela
- Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut
| | - R Hatz
- Thoraxchirurgisches Zentrum, Klinik für Allgemeine-, Viszeral-, Transplantations-, Gefäß- und Thoraxchirurgie, Klinikum Großhadern, Ludwig-Maximilians-Universität München; Asklepios Fachkliniken München-Gauting
| | - J Behr
- Asklepios Fachkliniken München-Gauting; Medizinische Klinik und Poliklinik V, Klinikum der Ludwig-Maximilians-Universität München, Member of the German Center of Lung Research (DZL)
| | - N Kaminski
- Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut
| | - A Schepers
- Monoclonal Antibody Core Unit, Monoclonal Antibody Research Group, Helmholtz-Zentrum München
| | - O Eickelberg
- Pulmonary and Critical Care Medicine University, Colorado Anschutz Medical Campus, Denver, Colorado
| | - C Staab-Weijnitz
- Comprehensive Pneumology Center, Helmholtz-Zentrum München, Member of the German Center of Lung Research (DZL)
| |
Collapse
|
38
|
Kreuter M, Ochmann U, Koschel D, Behr J, Bonella F, Claussen M, Costabel U, Jungmann S, Kolb M, Nowak D, Petermann F, Pfeiffer M, Polke M, Prasse A, Schreiber J, Wälscher J, Wirtz H, Kirsten D. Patientenfragebogen zur Erfassung der Ursachen interstitieller und seltener Lungenerkrankungen – klinische Sektion der DGP. Pneumologie 2018; 72:446-457. [DOI: 10.1055/s-0044-100207] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Zusammenfassung
Hintergrund Interstitielle Lungenerkrankungen (ILD) umfassen verschiedenste heterogene, zumeist chronische Erkrankungen des Interstitiums und/oder der Alveolen mit bekannten und unbekannten Ursachen. Die Diagnostik der ILD ist sehr komplex und sollte interdisziplinär erfolgen. Eine der wesentlichen Basisuntersuchungen ist eine umfangreiche Anamnese. Hierzu kam im deutschsprachigen Raum bisher der Frankfurter Bogen von 1985 zur Anwendung, der mittlerweile jedoch sprachlich und inhaltlich einer Überarbeitung bedurfte.
Methode Unter Schirmherrschaft der klinischen Sektion der DGP erfolgte die Erstellung eines neuen Patientenfragebogens zur Diagnostik interstitieller und seltener Lungenerkrankungen. Der Fragebogen entstand unter Mitarbeit von Pneumologen mit ILD-Expertise, Arbeitsmedizinern und Psychologen sowie der Unterstützung von Selbsthilfegruppen. Abschließend wurde der Fragebogen mithilfe von Patienten sprachlich optimiert.
Ergebnisse Der neu erstellte Patientenfragebogen zur Diagnostik interstitieller und seltener Lungenerkrankungen umfasst mehrere Bereiche: Initiale und aktuelle Symptome, Fragen zur Vorgeschichte inklusive Medikation, pulmonale und extrapulmonale Vorerkrankungen, mögliche Expositionen im häuslichen, privatem und beruflichem Umfeld sowie Familienanamnese und Reisetätigkeiten.
Schlussfolgerung Der neu erstellte Fragebogen kann in der klinischen Routine die Diagnostik bei Patienten mit Verdacht auf eine interstitielle Lungenerkrankung wesentlich erleichtern.
Collapse
Affiliation(s)
- M. Kreuter
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Thoraxklinik; Universitätsklinikum Heidelberg; Mitglied des Deutschen Zentrums für Lungenforschung
| | - U. Ochmann
- Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin; Klinikum der LMU München; Mitglied des Deutschen Zentrums für Lungenforschung
| | - D. Koschel
- Fachkrankenhaus Coswig; Zentrum für Pneumologie-, Thorax- und Gefäßchirurgie
| | - J. Behr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, LMU und Asklepios Fachkliniken München-Gauting, Mitglied des Deutschen Zentrums für Lungenforschung
| | - F. Bonella
- Ruhrlandklinik, Universitätsmedizin Essen
| | - M. Claussen
- LungenClinic Grosshansdorf; Mitglied des Deutschen Zentrums für Lungenforschung
| | | | | | - M. Kolb
- McMasters Universität, Hamilton, Canada
| | - D. Nowak
- Institut und Poliklinik für Arbeits-, Sozial- und Umweltmedizin; Klinikum der LMU München; Mitglied des Deutschen Zentrums für Lungenforschung
| | - F. Petermann
- Zentrum für Klinische Psychologie und Rehabilitation der Universität Bremen
| | - M. Pfeiffer
- Klinik Donaustauf und Universitätsklinikum Regensburg
| | - M. Polke
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Thoraxklinik; Universitätsklinikum Heidelberg; Mitglied des Deutschen Zentrums für Lungenforschung
| | - A. Prasse
- Medizinische Hochschule Hannover; Klinik für Pneumologie, Mitglied des Deutschen Zentrums für Lungenforschung
| | - J. Schreiber
- Universitätsklinik für Pneumologie, Universitätsklinikum Magdeburg
| | - J. Wälscher
- Zentrum für Interstitielle und Seltene Lungenerkrankungen, Thoraxklinik; Universitätsklinikum Heidelberg; Mitglied des Deutschen Zentrums für Lungenforschung
| | - H. Wirtz
- Universitätsklinikum der Universität Leipzig; Pneumologie
| | | |
Collapse
|
39
|
Hilgarth M, Behr J, Vogel R. Monitoring of spoilage-associated microbiota on modified atmosphere packaged beef and differentiation of psychrophilic and psychrotrophic strains. J Appl Microbiol 2018; 124:740-753. [DOI: 10.1111/jam.13669] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2017] [Revised: 11/17/2017] [Accepted: 12/05/2017] [Indexed: 11/28/2022]
Affiliation(s)
- M. Hilgarth
- Technische Universität München; Lehrstuhl für Technische Mikrobiologie; Freising Germany
| | - J. Behr
- Technische Universität München; Lehrstuhl für Technische Mikrobiologie; Freising Germany
| | - R.F. Vogel
- Technische Universität München; Lehrstuhl für Technische Mikrobiologie; Freising Germany
| |
Collapse
|
40
|
Silbernagel E, Morresi-Hauf A, Reu S, King B, Gesierich W, Lindner M, Behr J, Reichenberger F. Airway-centered interstitial fibrosis - an under-recognized subtype of diffuse parenchymal lung diseases. Sarcoidosis Vasc Diffuse Lung Dis 2018; 35:218-229. [PMID: 32476906 DOI: 10.36141/svdld.v35i3.6432] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 05/06/2017] [Accepted: 03/02/2018] [Indexed: 11/02/2022]
Abstract
Airway centered interstitial fibrosis (ACIF) has been recently suggesed as a rare histological pattern of interstitial lung disease of variable etiology and outcome. It is characterized by fibrosis of the respiratory bronchioles and the peribronchiolar interstitium. We describe the clinical features of 13 patients (7 female, mean age 55 years) with histologically proven ACIF in 12 cases and long-term follow up. In ten patients, exogenous agents could be detected (mould n=5, wood n=2, leather exposure n=1, occupational exposure n=2). Two patients had rheumatoid arthritis and 1 patient suffered from recurrent aspiration. In three patients no associated exposure could be detected. Eight patients were never-smokers, while five were ex- smokers. At time of diagnosis patients presented with a moderate restrictive ventilation impairment and sever reduction in diffusion capacity (VC 61%, TLC 66%, DLCOc-SB 38% pred.). All patients were started on immunosuppressive therapy with steroids which were combined with azathioprine in seven and with mycophenolate mofetil in one patient. Median time of follow up was 52 months (2-127 months). Patients with ACIF due to exogenous agents or associated with RA were stable with immunosuppressive therapy. One patient with idiopathic ACIF showed a progressive deterioration within 29 months despite immunosuppression and died while on a waiting-list for lung transplantation. In our experience ACIF is a rare finding, which is relatively frequently observed in the context of hypersensitivity pneumonitis, aspiration and rheumatoid arthritis, while idiopathic ACIF was a minority. In the majority of patients, ACIF showed a favorable long-term outcome with immunosuppressive therapy. (Sarcoidosis Vasc Diffuse Lung Dis 2018; 35: 218-229).
Collapse
Affiliation(s)
- E Silbernagel
- Department of Pneumology, Asklepios Lung Center Munich-Gauting
| | - A Morresi-Hauf
- Department of Pathology, Asklepios Lung Center Munich-Gauting
| | - S Reu
- Department of Pathology, Ludwig-Maximilians-University of Munich
| | - B King
- Department of Radiology, Asklepios Lung Center Munich-Gauting. Comprehensive Pneumology Center, Munich, Germany; Member of the German Center for Lung Research (DZL)
| | - W Gesierich
- Department of Pneumology, Asklepios Lung Center Munich-Gauting
| | - M Lindner
- Department of Thoracic Surgery Asklepios Lung Center Munich-Gauting
| | - J Behr
- Department of Pneumology, Asklepios Lung Center Munich-Gauting.,Department of Internal Medicine V, Ludwig-Maximilians-University of Munich
| | - F Reichenberger
- Department of Pneumology, Asklepios Lung Center Munich-Gauting
| |
Collapse
|
41
|
Milger K, Götschke J, Krause L, Nathan P, Alessandrini F, Tufman A, Fischer R, Bartel S, Theis FJ, Behr J, Dehmel S, Mueller NS, Kneidinger N, Krauss-Etschmann S. Identification of a plasma miRNA biomarker signature for allergic asthma: A translational approach. Allergy 2017; 72:1962-1971. [PMID: 28513859 DOI: 10.1111/all.13205] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/13/2017] [Indexed: 12/21/2022]
Abstract
BACKGROUND Asthma is a heterogeneous chronic disease with different phenotypes and treatment responses. Thus, there is a high clinical need for molecular disease biomarkers to aid in differentiating these distinct phenotypes. As MicroRNAs (miRNAs), that regulate gene expression at the post-transcriptional level, are altered in experimental and human asthma, circulating miRNAs are attractive candidates for the identification of novel biomarkers. This study aimed to identify plasmatic miRNA-based biomarkers of asthma, through a translational approach. METHODS We prescreened miRNAs in plasma samples from two different murine models of experimental asthma (ovalbumin and house dust mite); miRNAs deregulated in both models were further tested in a human training cohort of 20 asthma patients and 9 healthy controls. Candidate miRNAs were then validated in a second, independent group of 26 asthma patients and 12 healthy controls. RESULTS Ten miRNA ratios consisting of 13 miRNAs were differentially regulated in both murine models. Measuring these miRNAs in the training cohort identified a biomarker signature consisting of five miRNA ratios (7 miRNAs). This signature showed a good sensitivity and specificity in the test cohort with an area under the receiver operating characteristic curve (AUC) of 0.92. Correlation of miRNA ratios with clinical characteristics further revealed associations with FVC % predicted, and oral corticosteroid or antileukotriene use. CONCLUSION Distinct plasma miRNAs are differentially regulated both in murine and in human allergic asthma and were associated with clinical characteristics of patients. Thus, we suggest that miRNA levels in plasma might have future potential to subphenotype patients with asthma.
Collapse
Affiliation(s)
- K. Milger
- Department of Internal Medicine V; Comprehensive Pneumology Center; University of Munich; Munich Germany
- Member of the German Center for Lung Research (DZL); Munich Germany
- Institute of Lung Biology and Disease (ILBD); Helmholtz Center Munich; Comprehensive Pneumology Center (CPC-M); Munich Germany
| | - J. Götschke
- Department of Internal Medicine V; Comprehensive Pneumology Center; University of Munich; Munich Germany
- Member of the German Center for Lung Research (DZL); Munich Germany
- Institute of Lung Biology and Disease (ILBD); Helmholtz Center Munich; Comprehensive Pneumology Center (CPC-M); Munich Germany
| | - L. Krause
- Institute of Computational Biology; Helmholtz Center Munich; Munich Germany
| | - P. Nathan
- Member of the German Center for Lung Research (DZL); Munich Germany
- Institute of Lung Biology and Disease (ILBD); Helmholtz Center Munich; Comprehensive Pneumology Center (CPC-M); Munich Germany
| | - F. Alessandrini
- Member of the German Center for Lung Research (DZL); Munich Germany
- Center of Allergy and Environment (ZAUM); Technische Universität and Helmholtz Center Munich; Munich Germany
| | - A. Tufman
- Department of Internal Medicine V; Comprehensive Pneumology Center; University of Munich; Munich Germany
- Member of the German Center for Lung Research (DZL); Munich Germany
| | - R. Fischer
- Pneumologische Praxis München-Pasing; Munich Germany
| | - S. Bartel
- Member of the German Center for Lung Research (DZL); Munich Germany
- Early origins of chronic lung disease; Priority Area Asthma and Allergy; Research Center Borstel; Borstel Germany
- Airway Research Center North (ARCN); Borstel Germany
| | - F. J. Theis
- Institute of Computational Biology; Helmholtz Center Munich; Munich Germany
- Department of Mathematics; Technical University of Munich; Garching Germany
| | - J. Behr
- Department of Internal Medicine V; Comprehensive Pneumology Center; University of Munich; Munich Germany
- Member of the German Center for Lung Research (DZL); Munich Germany
| | - S. Dehmel
- Member of the German Center for Lung Research (DZL); Munich Germany
- Institute of Lung Biology and Disease (ILBD); Helmholtz Center Munich; Comprehensive Pneumology Center (CPC-M); Munich Germany
| | - N. S. Mueller
- Institute of Computational Biology; Helmholtz Center Munich; Munich Germany
| | - N. Kneidinger
- Department of Internal Medicine V; Comprehensive Pneumology Center; University of Munich; Munich Germany
- Member of the German Center for Lung Research (DZL); Munich Germany
| | - S. Krauss-Etschmann
- Member of the German Center for Lung Research (DZL); Munich Germany
- Institute of Lung Biology and Disease (ILBD); Helmholtz Center Munich; Comprehensive Pneumology Center (CPC-M); Munich Germany
- Early origins of chronic lung disease; Priority Area Asthma and Allergy; Research Center Borstel; Borstel Germany
- Airway Research Center North (ARCN); Borstel Germany
- Institute of Experimental Medicine; Christian-Albrechts-University of Kiel; Kiel Germany
| |
Collapse
|
42
|
Stelzer D, Weber A, Ihle F, Matthes S, Ceelen F, Zimmermann G, Kneidinger N, Schramm R, Winter H, Zoller M, Vogeser M, Behr J, Neurohr C. Posaconazole liquid vs tablet formulation in lung transplant recipients. Mycoses 2017; 61:186-194. [DOI: 10.1111/myc.12724] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2017] [Revised: 08/13/2017] [Accepted: 10/29/2017] [Indexed: 12/12/2022]
Affiliation(s)
- D. Stelzer
- Department of Internal Medicine V; LMU-Munich; Munich Germany
- Comprehensive Pneumology Center; Member of the German Center for Lung Research DZL; Munich Germany
- Hospital Pharmacy; LMU-Munich; Munich Germany
| | - A. Weber
- Hospital Pharmacy; LMU-Munich; Munich Germany
| | - F. Ihle
- Department of Internal Medicine V; LMU-Munich; Munich Germany
- Comprehensive Pneumology Center; Member of the German Center for Lung Research DZL; Munich Germany
| | - S. Matthes
- Department of Internal Medicine V; LMU-Munich; Munich Germany
- Comprehensive Pneumology Center; Member of the German Center for Lung Research DZL; Munich Germany
| | - F. Ceelen
- Department of Internal Medicine V; LMU-Munich; Munich Germany
- Comprehensive Pneumology Center; Member of the German Center for Lung Research DZL; Munich Germany
| | - G. Zimmermann
- Department of Internal Medicine V; LMU-Munich; Munich Germany
- Comprehensive Pneumology Center; Member of the German Center for Lung Research DZL; Munich Germany
| | - N. Kneidinger
- Department of Internal Medicine V; LMU-Munich; Munich Germany
- Comprehensive Pneumology Center; Member of the German Center for Lung Research DZL; Munich Germany
| | - R. Schramm
- Department of Cardiac Surgery; LMU-Munich; Munich Germany
| | - H. Winter
- Department of Thoracic Surgery; LMU-Munich; Munich Germany
| | - M. Zoller
- Department of Anesthesiology; LMU-Munich; Munich Germany
| | - M. Vogeser
- Institute of Laboratory Medicine; LMU-Munich; Munich Germany
| | - J. Behr
- Department of Internal Medicine V; LMU-Munich; Munich Germany
- Comprehensive Pneumology Center; Member of the German Center for Lung Research DZL; Munich Germany
| | - C. Neurohr
- Department of Internal Medicine V; LMU-Munich; Munich Germany
- Comprehensive Pneumology Center; Member of the German Center for Lung Research DZL; Munich Germany
| |
Collapse
|
43
|
Behr J, Günther A, Kreuter M, Koschel D, Prasse A, Pfeifer M, Costabel U. [Expert Knowledge and Supporting Advice for the Clinical Use of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis]. Pneumologie 2017; 71:567-579. [PMID: 28772332 DOI: 10.1055/s-0043-109856] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
In October 2016, a group of German IPF experts were invited by Boehringer Ingelheim to meet in Frankfurt with the aim, (a) to discuss relevant aspects of the management and treatment of idiopathic pulmonary fibrosis (IPF) using nintedanib; and, (b) to provide supportive advice for daily clinical practice with nintedanib. The resulting information compiled in this document is confined to practical issues regarding the use of nintedanib in patients with IPF. Where different therapeutic options were available, the choice of IPF medication was not discussed and the experts alluded to current guidelines for the diagnosis and treatment of IPF.The participants discussed a comprehensive spectrum of clinical questions related to 10 different topics, including patient-related aspects at initiation of IPF therapy, the treatment of anticoagulated IPF patients, and the handling of nintedanib-related adverse events such as gastrointestinal side effects and elevated liver enzymes. In addition, the experts evaluated therapeutic options for IPF patients with continuous disease progression, clinical scenarios that justify discontinuation of nintedanib treatment, and therapeutic options for IPF patients with an acute exacerbation or severe infection. Finally, the participants discussed the handling of nintendanib before/after elective surgical intervention (e. g. lung transplantation) and the current evidence for antifibrotic combination therapy in patients with IPF.For each topic discussed, the resulting information incorporates published evidence from clinical trials. In case of insufficient or lacking evidence, the experts have formulated recommendations based on their personal clinical experience and evaluation.
Collapse
Affiliation(s)
- J Behr
- Asklepios Fachkliniken München-Gauting und Medizinische Klinik V, Klinikum der Ludwig-Maximilians-Universität München
| | - A Günther
- Med. Klinik II, Klinische Forschergruppe "Lungenfibrose", Universitätsklinikum Gießen und Marburg.,Lungenfachklinik Waldhof-Elgershausen, Greifenstein
| | - M Kreuter
- Zentrum für seltene und interstitielle Lungenerkrankungen, Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg, Mitglied des Deutschen Zentrums für Lungenforschung
| | - D Koschel
- Abteilung Pneumologie, Fachkrankenhaus Coswig, Zentrum für Pneumologie, Allergologie, Beatmungsmedizin und Thoraxchirurgie
| | - A Prasse
- Klinik für Pneumologie, Medizinische Hochschule Hannover und Deutsches Zentrum für Lungenforschung BREATH.,Fraunhofer Institut ITEM Hannover
| | - M Pfeifer
- Zentrum für Pneumologie, Klinik Donaustauf
| | - U Costabel
- Ruhrlandklinik, Westdeutsches Lungenzentrum am Universitätsklinikum Essen, Essen
| |
Collapse
|
44
|
Mavi SC, Göres R, Shresta B, Maharjan B, Behr J, Avsar K, Hoffmann H. Aktive Fallfindung mit standardisiertem Behandlungsalgorithmus ermöglicht eine maßgebliche Verbesserung der Tuberkulose-Fallfindung von Kindern in Kathmandu/Nepal (TRACK). Pneumologie 2017. [DOI: 10.1055/s-0037-1598486] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- SC Mavi
- Zentrum für Pneumologie und Thoraxchirurgie, Asklepios Fachkliniken München-Gauting; Kuratorium Tuberkulose in der Welt e.V., Who-Supranational Reference Laboratory of Tuberculosis
| | - R Göres
- Zentrum für Pneumologie und Thoraxchirurgie, Asklepios Fachkliniken München-Gauting; Kuratorium Tuberkulose in der Welt e.V., Who-Supranational Reference Laboratory of Tuberculosis
| | | | | | - J Behr
- Zentrum für Pneumologie und Thoraxchirurgie, Asklepios Fachkliniken München-Gauting; Med. Klinik V, LMU, München, Mitglied des Dzl
| | - K Avsar
- Zentrum für Pneumologie und Thoraxchirurgie, Asklepios Fachkliniken München-Gauting; Kuratorium Tuberkulose in der Welt e.V., Who-Supranational Reference Laboratory of Tuberculosis
| | - H Hoffmann
- Synlab Mvz Gauting; Kuratorium Tuberkulose in der Welt e.V., Who-Supranational Reference Laboratory of Tuberculosis
| |
Collapse
|
45
|
Behr J, Pittrow D, Kreuter M, Prasse A, Klotsche J, Koschel D, Andreas S, Neurohr C, Claussen M, Schwaiblmair M, Grohé C, Wilkens H, Skowasch D, Kirschner J, Meyer FJ, Ewert R, Held M, Huber RM, Bahmer T, Gläser S, Welte T, Randerath WJ, Wirtz H. Klinischer Verlauf von Patienten mit Idiopathischer Lungenfibrose: aktuelle Daten aus dem INSIGHTS-IPF Register. Pneumologie 2017. [DOI: 10.1055/s-0037-1598290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- J Behr
- Zentrum für Pneumologie und Thoraxchirurgie, Asklepios Fachkliniken München-Gauting; Med. Klinik V, LMU München; Mitglied des Dzl
| | - D Pittrow
- Institut für Klinische Pharmakologie, Med. Fakultät, Technische Universität Dresden
| | - M Kreuter
- Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg und Translationales Zentrum für Lungenforschung Heidelberg (Tlrc); Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - A Prasse
- Klinik für Pneumologie, Medizinische Hochschule Hannover
| | - J Klotsche
- Epidemiologie, Deutsches Rheuma-Forschungszentrum
| | - D Koschel
- Zentrum für Pneumologie, Thorax- und Gefäßchirurgie, Fachkrankenhaus Coswig GmbH
| | - S Andreas
- Lungenfachklinik Immenhausen, Krs. Kassel; Pneumologische Lehrklinik Univ. Göttingen
| | - C Neurohr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Großhadern
| | - M Claussen
- Zentrum für Pneumologie und Thoraxchirurgie, Lungenclinic Großhansdorf
| | - M Schwaiblmair
- I. Medizinsche Klinik, Funktionsbereich Pneumologie, Klinikum Augsburg
| | - C Grohé
- Klinik für Pneumologie, Evangelische Lungenklinik Berlin
| | - H Wilkens
- Medizinische Klinik V, Universitätsklinikum des Saarlandes
| | - D Skowasch
- Medizinische Klinik II, Kardiologie, Pneumologie, Uniklinikum Bonn
| | | | - FJ Meyer
- Klinik für Pneumologie, Gastroenterologie, Internistische Intensiv- und Beatmungsmedizin, Klinikum München-Harlaching; Städt. Klinikum München GmbH
| | - R Ewert
- Zentrum für Innere Medizin, Klinik für Innere B, Bereich Pneumologie, Universitätsmedizin Greifswald, Körperschaft des Öffentlichen Rechts
| | - M Held
- Abteilung Innere Medizin Pneumologie, Missionsärztliche Klinik, Klinikum Würzburg Mitte
| | - RM Huber
- Sektion Pneumologie Innenstadt und Thorakale Onkologie, Universität München; Thoracic Oncology Centre Munich
| | | | - S Gläser
- Klinik und Poliklinik für Innere Medizin B, Bereich Pneumologie, Universitätsmedizin Greifswald; Klinik für Innere Medizin, Pneumologie, Vivantes Klinikum Spandau
| | - T Welte
- Klinik für Pneumologie, Medizinische Hochschule Hannover
| | - WJ Randerath
- Klinik für Pneumologie und Allergologie, Zentrum für Schlaf- und Beatmungsmedizin, Krankenhaus Bethanien GmbH
| | - H Wirtz
- Abteilung für Pneumologie, Universitätsklinikum Leipzig AöR
| |
Collapse
|
46
|
Munker D, Arnold P, Ceelen F, Kneidinger N, Leuschner G, Prechtl C, Matthes S, Veit T, Behr J, Neurohr C. Kortisonstoßtherapie bei Verschlechterung der Lungenfunktion nach Lungentransplantation und Ausschluss einer akuten zellulären Abstoßungsreaktion. Pneumologie 2017. [DOI: 10.1055/s-0037-1598292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- D Munker
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - P Arnold
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - F Ceelen
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - N Kneidinger
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - G Leuschner
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - C Prechtl
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - S Matthes
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - T Veit
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - C Neurohr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| |
Collapse
|
47
|
Leuschner G, Stocker F, Veit T, Kneidinger N, Ceelen F, Arnold P, Munker D, Matthes S, Behr J, Neurohr C. Lungentransplantation bei Patienten mit bestehender Pirfenidontherapie: eine Fallstudie. Pneumologie 2017. [DOI: 10.1055/s-0037-1598291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- G Leuschner
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - F Stocker
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - T Veit
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - N Kneidinger
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - F Ceelen
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - P Arnold
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - D Munker
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - S Matthes
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - C Neurohr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| |
Collapse
|
48
|
Ceelen F, Burger C, Kneidinger N, Matthes S, Leuschner G, Arnold P, Munker D, Veit T, Dinkel J, Behr J, Neurohr C. Stellenwert der Surveillance-Computertomografie nach Lungentransplantation. Pneumologie 2017. [DOI: 10.1055/s-0037-1598562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- F Ceelen
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - C Burger
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - N Kneidinger
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - S Matthes
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - G Leuschner
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - P Arnold
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - D Munker
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - T Veit
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - J Dinkel
- Institut für Klinische Radiologie, Klinikum der Universität München
| | - J Behr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - C Neurohr
- Medizinische Klinik und Poliklinik V, Klinikum der Universität München, Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| |
Collapse
|
49
|
Kreuter M, Wacker M, Hammerl P, Wiederhold C, Kabitz HJ, Hagmeyer L, Skowasch D, Leidl R, Hellmann A, Pfeifer M, Behr J, Witt S, Kauschka D, Mall M, Günther A, Herth FJF, Markart P. Interims Analyse des EXCITING-ILD Registers (Registry for Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases). Pneumologie 2017. [DOI: 10.1055/s-0037-1598497] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- M Kreuter
- Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg und Translationales Zentrum für Lungenforschung Heidelberg (Tlrc), Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - M Wacker
- Helmholtz Zentrum München, Institut für Gesundheitsökonomie und Management Im Gesundheitswesen, Comprehensive Pneumology Center Munich (Cpc-M), Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | | | | | - HJ Kabitz
- II. Medizinische Klinik, Klinikum Konstanz
| | - L Hagmeyer
- Klinik für Pneumologie und Allergologie, Krankenhaus Bethanien gGmbH
| | - D Skowasch
- Medizinische Klinik II, Kardiologie, Pneumologie, Uniklinikum Bonn
| | - R Leidl
- Institut für Gesundheitsökonomie und Management Im Gesundheitswesen, Helmholtz Zentrum München, Comprehensive Pneumology Center Munich (Cpc-M), Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | | | - M Pfeifer
- Krankenhaus Donaustauf; Universität Regensburg
| | - J Behr
- Zentrum für Pneumologie und Thoraxchirurgie, Asklepios Fachkliniken München-Gauting; Med. Klinik V, LMU, München, Mitglied des Dzl
| | - S Witt
- Institut für Gesundheitsökonomie und Management Im Gesundheitswesen, Helmholtz Zentrum München
| | - D Kauschka
- C/O Dagmar Kauschka, 1. Vorsitzende, Lungenfibrose e.V
| | - M Mall
- Zentrum für Kinder- und Jugendmedizin, Sektion Pädiatrische Pneumologie & Allergologie und Mukoviszidose-Zentrum, Universitätsklinikum Heidelberg
| | - A Günther
- Med. Klinik II, Schwerpunkt Pneumologie, Univ.-Klinikum Gießen
| | - FJF Herth
- Pneumologie und Beatmungsmedizin, Thoraxklinik, Universitätsklinikum Heidelberg und Translationales Zentrum für Lungenforschung Heidelberg (Tlrc), Mitglied des Deutschen Zentrums für Lungenforschung (Dzl)
| | - P Markart
- Medizinische Klinik V, Klinikum Fulda
| |
Collapse
|
50
|
Kneidinger N, Milger K, Janitza S, Ceelen F, Leuschner G, Königshoff M, Weig T, Schramm R, Winter H, Behr J, Neurohr C. Lung volumes predict survival in patients with chronic lung allograft dysfunction. Pneumologie 2017. [DOI: 10.1055/s-0037-1598295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- N Kneidinger
- Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL) & Munich Lung Transplant Group (MLTG), University of Munich, Germany
| | - K Milger
- Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL) & Munich Lung Transplant Group (MLTG), University of Munich, Germany
| | - S Janitza
- Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL) & Munich Lung Transplant Group (MLTG), University of Munich, Germany
| | - F Ceelen
- Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL) & Munich Lung Transplant Group (MLTG), University of Munich, Germany
| | - G Leuschner
- Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL) & Munich Lung Transplant Group (MLTG), University of Munich, Germany
| | - M Königshoff
- Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL) & Munich Lung Transplant Group (MLTG), University of Munich, Germany
| | - T Weig
- Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL) & Munich Lung Transplant Group (MLTG), University of Munich, Germany
| | - R Schramm
- Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL) & Munich Lung Transplant Group (MLTG), University of Munich, Germany
| | - H Winter
- Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL) & Munich Lung Transplant Group (MLTG), University of Munich, Germany
| | - J Behr
- Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL) & Munich Lung Transplant Group (MLTG), University of Munich, Germany
| | - C Neurohr
- Department of Internal Medicine V, Comprehensive Pneumology Center (CPC-M), Member of the German Center for Lung Research (DZL) & Munich Lung Transplant Group (MLTG), University of Munich, Germany
| |
Collapse
|